🇺🇸 FDA
Pipeline program

Trastuzumab in Combination with TS-ONE and cisplatin

S1/CDDP/Her

Phase 2 small_molecule active

Quick answer

Trastuzumab in Combination with TS-ONE and cisplatin for Gastric Cancer is a Phase 2 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Gastric Cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials